IMO-8400

· Idera Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IMO-8400, covering 2017-11-13 to 2019-10-10. Get the full timeline:

Most recent: Clinical Trial Update: Trial of IMO-8400 in Adult Patients With Dermatomyositis [Phase 2]